BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 9221762)

  • 1. Interleukin 4 (IL-4) or IL-7 prevents the death of resting T cells: stat6 is probably not required for the effect of IL-4.
    Vella A; Teague TK; Ihle J; Kappler J; Marrack P
    J Exp Med; 1997 Jul; 186(2):325-30. PubMed ID: 9221762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-4-mediated protection of primary B cells from apoptosis through Stat6-dependent up-regulation of Bcl-xL.
    Wurster AL; Rodgers VL; White MF; Rothstein TL; Grusby MJ
    J Biol Chem; 2002 Jul; 277(30):27169-75. PubMed ID: 12023955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The trophic action of IL-7 on pro-T cells: inhibition of apoptosis of pro-T1, -T2, and -T3 cells correlates with Bcl-2 and Bax levels and is independent of Fas and p53 pathways.
    Kim K; Lee CK; Sayers TJ; Muegge K; Durum SK
    J Immunol; 1998 Jun; 160(12):5735-41. PubMed ID: 9637482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-4-dependent induction of BCL-2 and BCL-X(L)IN activated T lymphocytes through a STAT6- and pi 3-kinase-independent pathway.
    Aronica MA; Goenka S; Boothby M
    Cytokine; 2000 Jun; 12(6):578-87. PubMed ID: 10843732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-7 enhances the survival and maintains the size of naive T cells.
    Rathmell JC; Farkash EA; Gao W; Thompson CB
    J Immunol; 2001 Dec; 167(12):6869-76. PubMed ID: 11739504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-4 elicits apoptosis of developing mast cells via a Stat6-dependent mitochondrial pathway.
    Bailey DP; Kashyap M; Mirmonsef P; Bouton LA; Domen J; Zhu J; Dessypris EN; Ryan JJ
    Exp Hematol; 2004 Jan; 32(1):52-9. PubMed ID: 14725901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stat6 and IRS-2 cooperate in interleukin 4 (IL-4)-induced proliferation and differentiation but are dispensable for IL-4-dependent rescue from apoptosis.
    Wurster AL; Withers DJ; Uchida T; White MF; Grusby MJ
    Mol Cell Biol; 2002 Jan; 22(1):117-26. PubMed ID: 11739727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single cell analysis reveals that IL-4 receptor/Stat6 signaling is not required for the in vivo or in vitro development of CD4+ lymphocytes with a Th2 cytokine profile.
    Jankovic D; Kullberg MC; Noben-Trauth N; Caspar P; Paul WE; Sher A
    J Immunol; 2000 Mar; 164(6):3047-55. PubMed ID: 10706693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Th2 differentiation and GATA-3 expression by BCL-6.
    Kusam S; Toney LM; Sato H; Dent AL
    J Immunol; 2003 Mar; 170(5):2435-41. PubMed ID: 12594267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-15 prevents mouse mast cell apoptosis through STAT6-mediated Bcl-xL expression.
    Masuda A; Matsuguchi T; Yamaki K; Hayakawa T; Yoshikai Y
    J Biol Chem; 2001 Jul; 276(28):26107-13. PubMed ID: 11369758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stat6 inhibits human interleukin-4 promoter activity in T cells.
    Georas SN; Cumberland JE; Burke TF; Chen R; Schindler U; Casolaro V
    Blood; 1998 Dec; 92(12):4529-38. PubMed ID: 9845517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-7 reconstitutes multiple aspects of v-Abl-mediated signaling.
    Banerjee A; Rothman P
    J Immunol; 1998 Nov; 161(9):4611-7. PubMed ID: 9794389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-4-mediated development of TGF-beta1-producing cells from naïve CD4(+) T cells through a STAT6-independent mechanism.
    Kohyama M; Sugahara D; Hosokawa H; Kubo M; Hozumi N
    Eur J Immunol; 2001 Dec; 31(12):3659-66. PubMed ID: 11745386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional repression of Stat6-dependent interleukin-4-induced genes by BCL-6: specific regulation of iepsilon transcription and immunoglobulin E switching.
    Harris MB; Chang CC; Berton MT; Danial NN; Zhang J; Kuehner D; Ye BH; Kvatyuk M; Pandolfi PP; Cattoretti G; Dalla-Favera R; Rothman PB
    Mol Cell Biol; 1999 Oct; 19(10):7264-75. PubMed ID: 10490661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-4-induced activation of the Stat6 pathway contributes to the suppression of cell-mediated immunity and death in sepsis.
    Song GY; Chung CS; Chaudry IH; Ayala A
    Surgery; 2000 Aug; 128(2):133-8. PubMed ID: 10922982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Costimulation of resting B lymphocytes alters the IL-4-activated IRS2 signaling pathway in a STAT6 independent manner: implications for cell survival and proliferation.
    Zamorano J; Kelly AE; Austrian J; Wang HY; Keegan AD
    Cell Res; 2001 Mar; 11(1):44-54. PubMed ID: 11305324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-4-induced transcriptional activation by stat6 involves multiple serine/threonine kinase pathways and serine phosphorylation of stat6.
    Pesu M; Takaluoma K; Aittomäki S; Lagerstedt A; Saksela K; Kovanen PE; Silvennoinen O
    Blood; 2000 Jan; 95(2):494-502. PubMed ID: 10627454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. STAT6 is required for the regulation of IL-4-induced cytoskeletal events in B cells.
    Davey EJ; Greicius G; Thyberg J; Severinson E
    Int Immunol; 2000 Jul; 12(7):995-1003. PubMed ID: 10882411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bi-phasic effect of interferon (IFN)-alpha: IFN-alpha up- and down-regulates interleukin-4 signaling in human T cells.
    Eriksen KW; Sommer VH; Woetmann A; Rasmussen AB; Brender C; Svejgaard A; Skov S; Geisler C; Ødum N
    J Biol Chem; 2004 Jan; 279(1):169-76. PubMed ID: 14559900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stat6-dependent and -independent pathways for IL-4 production.
    Kaplan MH; Wurster AL; Smiley ST; Grusby MJ
    J Immunol; 1999 Dec; 163(12):6536-40. PubMed ID: 10586046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.